Five Star Stock Watch

The first quarter of the year brought with it some major selling in the momentum names, specifically in biotech stocks. Since then, the overall stock market has recovered, and so have most biotech stocks with it. Unfortunately, while the market has hit new highs, most biotechs have not. Some...

It seems as if mergers and acquisitions in the healthcare sector has become commonplace, with a lot of biotech companies being main targets. Not a week goes by without multiple discussions about the battle between Valeant Pharmaceuticals (NYSE: VRX) and Allergan(NYSE: AGN). Last week brought...

Most biotech stocks have recovered, at least to some extent, during the overall stock market’s most recent run to new highs. However, some haven’t. Wall Street has been betting heavily against Arena Pharmaceuticals (NASDAQ: ARNA). Arena is one of the most heavily shorted biotech...

Most biotech stocks can move rapidly, and that’s one of the reasons why a lot of traders like them. Yes, the stocks can certainly be volatile, but when the gains come, they tend to come in bunches. The trick can be knowing how to identify when one of those “bunches” may be...

It isn’t a surprise to most that the biotech names have had a rough start to the year. Really, March was pretty bad. However, with the market recovering as of late, many of the beaten up biotech stocks have rebounded somewhat. A lot of analysts believe the rebound will continue. As an...

Last week, Investor’s Business Daily (IBD) released its IBD 50 list of highly rated stocks. This computer-generated list ranks U.S. stocks based on key metrics, including recent profit growth and IBD's Composite Rating. The composite rating measures return on equity, sales growth and profit...

Well, the last week has gotten just a bit better for Bristol-Myers Squibb (NYSE: BMY) thanks to the Federal Drug Administration. Bristol-Myers won its second breakthrough therapy designation from the FDA in under a week’s time. Just days after getting the FDA's elite status for its closely-...

When a company misses earnings, the negative news doesn’t always affect the underlying stock as expected. This is why it is always important to do your homework on the stock, rather than just on the company. Jazz Pharmaceuticals on May 9 missed analysts’ estimates. The stock dropped initially...

Tesla has been the beneficiary of good earnings receptions over the last few quarters, but maybe not this time. After the bell Wednesday, the company reported a loss of $49.8 million for the first quarter as research and development costs surged. Revenue was $620.5 million, up ten percent...

Most tech stocks haven’t been in vogue lately, especially some of the big names like Netflix, Amazon and Google. However, one big tech name has been bucking the tech down trend over the last few months, and that's Oracle. Although Oracle isn’t the best trading stock, it certainly is on a lot...

Google's first quarter revenue missed Wall Street's estimates thanks to narrowing margins due to continuing price declines for its ads. The stock had intially dropped around six percent after hours last night, but somewhat recovered quickly thereafter. So, what should Google traders and...

Copper has been trending lower for the last few years having hit a new low back in March. Gold has also been trending lower since hitting its high back in the summer of 2011. These trends have certainly affected copper and gold stocks, but what about THE copper and gold stock, Freeport-...